Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06577948Not ApplicableActive Not Recruiting

The P.A.U.S.E.® Spectacle Study

Role: lead

NCT05243836Not ApplicableActive Not Recruiting

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

Role: lead

NCT06878118Not ApplicableRecruiting

The A.R.R.E.S.T.® Contact Lens Study

Role: lead

NCT06692699Not ApplicableRecruiting

The A.R.R.E.S.T.® Spectacle Film Study

Role: lead

NCT06137560Not ApplicableRecruiting

Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children

Role: lead

All 5 trials loaded